<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02477124</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00052865</org_study_id>
    <nct_id>NCT02477124</nct_id>
  </id_info>
  <brief_title>A See and Treat Paradigm for Cervical Pre-cancer</brief_title>
  <official_title>A See and Treat Paradigm for Cervical Pre-cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if the transvaginal colposcope produces similar results
      to colposcopy for the screening of cervical cancer. In this study the investigators are using
      an investigational device called the transvaginal colposcope. The word investigational means
      that the device is still being tested in research studies and is not approved by the U.S.
      Food and Drug Administration (FDA).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concordance of the TVDC to standard of care, as measured by weighted kappa statistic</measure>
    <time_frame>Up to approximately 10 minutes</time_frame>
    <description>The level of agreement between the standard of care diagnosis and the diagnosis of the TVDC images will be reported.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cervical Pre-cancer</condition>
  <arm_group>
    <arm_group_label>transvaginal digital colposcope (TVCD)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each enrolled patient will undergo the standard of care for cervical cancer screening at her institution, and then the trans-vaginal colposcope will be used to collect digital images of the cervix.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard of care screening</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each enrolled patient will undergo the standard of care for cervical cancer screening at her institution, and then the trans-vaginal colposcope will be used to collect digital images of the cervix.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transvaginal digital colposcope (TVDC)</intervention_name>
    <description>TVDC is a miniature colposcope used to obtain images of cervical tissue.</description>
    <arm_group_label>transvaginal digital colposcope (TVCD)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care screening</intervention_name>
    <description>Standard of care screening varies from institution to institution but is either visual inspection with the naked eye, colposcopy, or visual inspection with a camera or microscope</description>
    <arm_group_label>standard of care screening</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing cervicography OR colposcopy OR VIA OR patients undergoing LEEP for
             the treatment of cervical cancer.

          -  Age 25 and greater

          -  Patients of all ethnic backgrounds will be included.

          -  Ability to understand and the willingness to sign a written informed consent document.

        Exclusion Criteria:

          -  Children and subjects under 25.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nirmala Ramanujam, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marlee S Krieger, M.S</last_name>
    <phone>919-660-8446</phone>
    <email>marlee.krieger@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nimmi Ramanujam, Ph.D.</last_name>
      <phone>919-660-5307</phone>
      <email>nimmi@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Nimmi Ramanujam, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>La Liga Contra el Cancer</name>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gino Venegas, MD</last_name>
      <phone>(51)998254182</phone>
      <email>ginovenegas@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kilimanjaro Christian Medical Centre</name>
      <address>
        <city>Moshi</city>
        <country>Tanzania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bariki Mchome</last_name>
      <phone>+255786280027</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Teaching Hospital</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Groesbeck Parham, MD</last_name>
      <phone>0978-124392</phone>
      <email>rofessorparham@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Peru</country>
    <country>Tanzania</country>
    <country>United States</country>
    <country>Zambia</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2015</study_first_submitted>
  <study_first_submitted_qc>June 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2015</study_first_posted>
  <last_update_submitted>April 26, 2017</last_update_submitted>
  <last_update_submitted_qc>April 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Dysplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

